BAKER BROS. ADVISORS LP, Director, bought 11,764,705 shares of the ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) in an exchange that happened on November 30th. The stock was bought at an average price of $17.00 per share, amounting to a transaction worth $199,999,985. The purchase was made public in a document filed with the SEC. Additionally, Director BAKER BROS. ADVISORS LP bought 1,210,776 shares of this stock in a transaction that took place on September 20th. The stock was bought at an average price of $18.70 per share, for a total exchange amounting to $22,646,989. After the transaction, the Director BAKER BROS. ADVISORS LP currently holds 24,798,117 shares of the company’s stock, which is worth approximately $513569003.
With this stock price’s latest movement, it is now -37.22% away from its 1-year high and 62.18% higher than its 1-year low price. In the past seven days, the stock price volatility for ACADIA Pharmaceuticals Inc. was 7.37%, whereas its volatility in the past 30 days has been 7.09%. This public company’s stock also has a beta score of 3.08. When the beta value is less/more than 1, it can imply that the stock is less/more volatile than the wider stock market – a metric that traders will surely be keeping tabs on.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) most recently published its quarterly earnings results. The firm posted -$0.50 earnings per share (EPS) for the three-month period, surpassing analysts’ consensus estimate of -$0.58 by $0.08. The publicly-traded organization reported revenue of $58.31 million for the quarter, compared to the average analyst forecast calling for $56.07 million, which was surpassing the analyst consensus estimate.
Shares of ACADIA Pharmaceuticals Inc. (ACAD) surged 4.91%, amounting to a gain of $0.97 per share, to finish the regular trading session at $20.71 on Thursday 01/10/2019. After beginning the session at $19.67, shares of ACADIA Pharmaceuticals Inc. reached as high as $20.975 during the day, while hitting a 1-day low of $19.35. Trade volume reached 2,524,104 shares against this stock’s average daily volume of 2.50M shares, with a total float of 101.14M. As a consequence of the price increase, ACADIA Pharmaceuticals Inc. now has a current market value of 2.77B.
TAL Education Group (NYSE:TAL) added 0.24% to its trading price by the close of the most recent session, jumping from its previous closing price of $28.95 to $29.02. This stock increased in value by 17.35% during the last 7-day period, and experienced a gain of 7.88% over the past 30-day period. In the past three months, this stock’s price grew by 24.82% , and subtracted -23.15% to its price during the last six months of trading. TAL demonstrated a yearly price loss of -12.56% , while its year-to-date (YTD) price performance has been up 8.77% . This stock’s price changed by +37.67% compared to its 90-day low, and moved down -4.48% comparing to its 90-day high price.
Have a quick look on short, medium and long-term indicators. According to the Composite Indicator, Trendspotter rated the TAL stock as “Buy”. In the short-term, TAL Education Group (TAL) has a 20-day average volume of 3,241,860 shares and short-term indicators sets the TAL stock as “ 60% Buy ” on average basis. In the medium-term, TAL stock has a 50-Day average volume of 4,050,178 shares and medium-term indicators gave the average rating of “ 25% Buy ”, while in the long-term period the FB stock has a 100-Day average volume of 5,197,274 shares. On average, long-term indicators rated the stock as “67% Buy ”. The overall picture from all short, medium and long-term indicators sets the TAL stock as “56% Buy ” on average basis.
Recently, multiple brokerages have sent out reports on TAL. Citigroup, for example, Upgrade its rating on shares of TAL Education Group from “Neutral ” to a “ Buy”according to a research note from Wednesday January 9th, 2019. The Benchmark Company Reiterated their target price for this stock from $37 to $42, while giving the stock a “Buy” rating, as stated in a research report from Friday, April 27th, 2018. CLSA, on the other hand, Downgrade a from “Buy ” to “ Outperform” rating on this stock in a research note dated Wednesday, April 4th, 2018.
In other news related to TAL Education Group stock, Age shares of TAL held by institutions. The total number of institutions who held the TAL shares was 36, according to most recent SEC filling. During the past quarter, total 35 shares held by institutions with the net change of 37 shares. In the meantime, 35 new institutions bought the shares of TAL Education Group for the first time and 33 institutions sold all their holdings in the company’s common stock. 47 institutions increased their investment in the TAL stock and 48 institutions decreased their investment in the TAL Education Group (TAL)’s stock during the last quarter.